Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D N O'Neal

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Drugs|June 14, 2000
Diabetic dyslipidaemia: current treatment recommendationsJ D Best, D N O'Neal
Australian Family Physician|September 1, 1993
Diabetes and vascular diseaseJ D Best, D N O'Neal
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 30, 1999
The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapyD N O'Neal, F L Hew, J D Best, et al.
Atherosclerosis|April 17, 1998
Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjectsD N O'Neal, J Lewicki, M Z Ansari, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 24, 1997
Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetesS F O'Brien, G F Watts, D A Playford, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 4, 2012
Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunctionA S Januszewski, N Sachithanandan, C Karschimkus, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1994
The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysisD N O'Neal, A Kalfas, P L Dunning, et al.
The American Journal of Clinical Nutrition|May 9, 2000
Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic menT A Mori, V Burke, I B Puddey, et al.
Atherosclerosis|July 5, 2008
Australian Aboriginal people and Torres Strait Islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particlesD N O'Neal, L S Piers, D M Iser, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 29, 2017
Asymmetric changes in circulating insulin levels after an increase compared with a reduction in insulin pump basal rate in people with Type 1 diabetesS A McAuley, G M Ward, J C Horsburgh, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Drugs|June 14, 2000
Diabetic dyslipidaemia: current treatment recommendationsJ D Best, D N O'Neal
Australian Family Physician|September 1, 1993
Diabetes and vascular diseaseJ D Best, D N O'Neal
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|September 30, 1999
The effect of 24 months recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo [a] in hypopituitary adults previously treated with conventional replacement therapyD N O'Neal, F L Hew, J D Best, et al.
Atherosclerosis|April 17, 1998
Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjectsD N O'Neal, J Lewicki, M Z Ansari, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 24, 1997
Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetesS F O'Brien, G F Watts, D A Playford, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|January 4, 2012
Non-invasive measures of tissue autofluorescence are increased in Type 1 diabetes complications and correlate with a non-invasive measure of vascular dysfunctionA S Januszewski, N Sachithanandan, C Karschimkus, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1994
The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysisD N O'Neal, A Kalfas, P L Dunning, et al.
The American Journal of Clinical Nutrition|May 9, 2000
Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic menT A Mori, V Burke, I B Puddey, et al.
Atherosclerosis|July 5, 2008
Australian Aboriginal people and Torres Strait Islanders have an atherogenic lipid profile that is characterised by low HDL-cholesterol level and small LDL particlesD N O'Neal, L S Piers, D M Iser, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 29, 2017
Asymmetric changes in circulating insulin levels after an increase compared with a reduction in insulin pump basal rate in people with Type 1 diabetesS A McAuley, G M Ward, J C Horsburgh, et al.
Pageof 2